Mortality News and Research

RSS

Non-pharmaceutical interventions effectively reduce COVID case burden in the United States

A new study analyzes the impact of non-pharmaceutical interventions in the United States against SARS-CoV-2 transmission.

3 Oct 2021

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

A recent study discusses the rate of changes in peripheral blood white cells in individuals who have recovered from SARS-CoV-2 infection.

3 Oct 2021

Study analyzes plausible associations of COVID-19 mortality and excess body weight

Links between obesity and mortality have become increasingly evident, since the earliest pandemic of the 21st century, leading researchers from The University of Texas at San Antonio and the University of Wisconsin-Milwaukee to investigate if excess body weight may have been associated with high rates of COVID-19 mortalities around the globe.

3 Oct 2021

Hospitalizations related to COVID-19 can be reduced by using prescribed blood thinners

The NIH has reported that many individuals with COVID-19 develop abnormal blood clots from high inflammation, which can lead to serious health complications and mortality.

3 Oct 2021

Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy

Osimertinib was the first drug to be approved for adjuvant treatment after complete tumour resection in adults with stage IB to IIIA non-small cell lung cancer (NSCLC).

2 Oct 2021

KHN’s ‘What the Health?’: The health agenda still on hold

Meanwhile, the Biden administration issued regulations to implement last year's law to limit "surprise" medical bills to patients who get care outside their insurance networks.

1 Oct 2021

Structure of monoclonal antibody that can potently neutralize SARS-CoV-2 and variants of concern

A new preprint deals with the analysis of the monoclonal antibody J08, which was capable of powerful neutralization of the wildtype SARS-CoV-2, and its VOCs.

1 Oct 2021

Persistence of humoral immune response in SARS-CoV-2 convalescent individuals a year after infection

A new study reported the persistence of immune responses over twelve months after natural infection.

1 Oct 2021

Similar viral load in vaccinated and unvaccinated individuals infected with SARS-CoV-2 Delta variant

Researchers evaluated Ct-values among distinct groups, namely, a) completely vaccinated and unvaccinated individuals and b) asymptomatic and symptomatic individuals at the time of testing.

1 Oct 2021

Research shows dramatic decline in colorectal cancer diagnoses during the pandemic

The number of colorectal cancer cases diagnosed fell dramatically by 40% in a year during the COVID-19 pandemic, new research presented today at UEG Week Virtual 2021 has shown.

1 Oct 2021

A call to action for reducing health disparities and advancing treatments for Parkinson's patients

Current knowledge about Parkinson's disease (PD) does not reflect the diversity of people with the disease, according to The Michael J. Fox Foundation for Parkinson's Research (MJFF).

1 Oct 2021

Small sachet of fortified food-based supplement could promote healthy development of children

A small sachet of a fortified food-based supplement added to young children's daily diets in low- and middle-income countries has shown remarkable results in preventing child mortality and malnutrition, while also promoting healthy development.

30 Sep 2021

Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy

Cancer immunotherapy seeks to turn "cold" tumors into "hot" tumors––those that respond to immunotherapy––by awakening and enlisting the body's own immune system.

30 Sep 2021

Non-severe COVID-19 may elicit more durable memory B cell response than severe COVID-19

A recent study conducted by researchers from the US aimed to measure the impact of severity of COVID-19 on memory B cell response and characterize changes in the memory B cell compartment during the period between recovery and five months after symptom onset. This study is available on the bioRxiv* preprint server.

30 Sep 2021

Immigration adds 1.4 to 1.5 years to U.S. life expectancy, study says

If immigrants to the United States formed their own country, their pre-COVID-19 life expectancies would exceed or match those of the world's leaders in longevity - Swiss men and Japanese women.

30 Sep 2021

The connection between age and virulence of SARS-CoV-2 variants of concern

A new study focuses on determining the existence of an age-related heterogeneity in the severity of COVID-19.

30 Sep 2021

Covid is killing rural Americans at twice the rate of urbanites

Rural Americans are dying of covid at more than twice the rate of their urban counterparts — a divide that health experts say is likely to widen as access to medical care shrinks for a population that tends to be older, sicker, heavier, poorer and less vaccinated.

30 Sep 2021

People living at higher altitudes have a lower risk of stroke and stroke-related death, finds study

Could living at high altitudes affect your chance of suffering a stroke? This intriguing question is at the heart of a new study in open-access journal Frontiers in Physiology.

30 Sep 2021

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that Teresa H. Evering, M.D., M.S., a co-lead investigator (with Eric S. Daar, M.D.) for BRII-196/BRII-198 in the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies, will present data for the monoclonal antibody combination at the virtual IDWeek 2021 conference, taking place September 29 – October 3, 2021.

30 Sep 2021

Instrument to measure risk of reverse zoonotic SARS-CoV-2 transmission events from humans to animals

A new study published on the medRxiv* preprint server presents a standardized survey instrument for evaluating risk factors associated with bidirectional zoonotic transmission of SARS-CoV-2 and pathogens. The instrument is particularly focused on settings where humans and animals share close contact.

30 Sep 2021

Mortality News and Research

Non-pharmaceutical interventions effectively reduce COVID case burden in the United States

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

Study analyzes plausible associations of COVID-19 mortality and excess body weight

Hospitalizations related to COVID-19 can be reduced by using prescribed blood thinners

Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy

KHN’s ‘What the Health?’: The health agenda still on hold

Structure of monoclonal antibody that can potently neutralize SARS-CoV-2 and variants of concern

Persistence of humoral immune response in SARS-CoV-2 convalescent individuals a year after infection

Similar viral load in vaccinated and unvaccinated individuals infected with SARS-CoV-2 Delta variant

Research shows dramatic decline in colorectal cancer diagnoses during the pandemic

A call to action for reducing health disparities and advancing treatments for Parkinson's patients

Small sachet of fortified food-based supplement could promote healthy development of children

Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy

Non-severe COVID-19 may elicit more durable memory B cell response than severe COVID-19

Immigration adds 1.4 to 1.5 years to U.S. life expectancy, study says

The connection between age and virulence of SARS-CoV-2 variants of concern

Covid is killing rural Americans at twice the rate of urbanites

People living at higher altitudes have a lower risk of stroke and stroke-related death, finds study

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

Instrument to measure risk of reverse zoonotic SARS-CoV-2 transmission events from humans to animals

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News